COVID
Kit, and is inspired by the idea of locating and using new combinations of existing community resources to help cities, counties and states develop pandemic recovery strategies. Its backbone is the ROCKit Blueprint, which helps communities prioritize recovery efforts by focusing on the needs of vulnerable people and economic sectors that have been most impacted by COVID-19. Communities face multiple competing crises in addition to COVID, and leaders are exhausted with planning fatigue, said Christine Bechtel, co-founder, X4 Health. Our goal in building the Blueprint tool was simple: curate some of the best plans available and create a free resource anyone can use to make their own planning process easier.
IceCure Signs Exclusive Distribution Agreement with Rise General Trading, LCC, Expanding Market Reach Across the Middle East
USA - English
News provided by
Share this article
Share this article
CAESAREA, Israel, Feb. 17, 2021 /PRNewswire/ IceCure Medical Ltd. (TASE: ICCM) ( IceCure or the Company ), developer of the next generation cryoablation technology that destroys tumors by freezing without the need for surgery, today announced an exclusive distribution agreement with Rise General Trading, LLC for IceCure s ProSense® Cryoablation System in the United Arab Emirates and Arabian Gulf States ( the territories ).
Under the terms of the agreement, Rise General Trading, LCC will purchase a minimum amount of approximately $16 million USD of IceCure s products over a period of three years. The first purchase order will be executed within three months after the receipt of all regulatory licenses necessary for the sale of IceCure s products in the first territory. Licenses req
/PRNewswire/ Teledentistry.com has partnered with the University of Nevada-Las Vegas (UNLV) School of Dental Medicine, Liberty Dental Plan, the Nevada.
Almirall and MC2 Therapeutics enter a license, collaboration and commercialization agreement for European rights to Wynzora® Cream for treatment of plaque psoriasis
USA - English In this collaboration Almirall will commercialize Wynzora® Cream for treatment of plaque psoriasis in Europe and MC2 Therapeutics will be responsible for manufacturing and supply MC2 Therapeutics and Almirall partner to make Wynzora® Cream a leading topical product for Plaque Psoriasis in Europe In a large European based Phase 3 clinical trial (n=490), Wynzora® Cream has demonstrated substantial efficacy with a PGA treatment success of 51% and beneficial treatment convenience[1] Marketing Authorization Application (MAA) in Europe of Wynzora® Cream has been filed and approval is expected this year
TheraNow Launches Telehealth Pain Relief Solution
Leader in groundbreaking technology and services in the field of pain management provides virtual exercise-based rehabilitation with live certified therapists and health experts
News provided by
Share this article
Share this article
TYLER, Texas, Feb. 17, 2021 /PRNewswire/ TheraNow, a pioneer in telehealth rehabilitation and online physical therapy services, today announced the launch of their new mobile app and web platform for effective pain relief. TheraNow is a leading HIPAA compliant solution that provides convenient and reliable online therapeutic services through board certified physical therapists and health experts across the nation through video consultations.
TheraNow is a leading HIPAA compliant solution that provides convenient and reliable online therapeutic services through board certified physical therapists and health experts across the nation through video consultations.